CHA Vaccine Research Institute (KOSDAQ:261780)
South Korea
· Delayed Price · Currency is KRW 2,935.00
-5.00 (-0.17%)
At close: Dec 5, 2025
KOSDAQ:261780 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Net Income | -14,251 | -10,138 | -1,749 | -6,715 | -18,420 | -6,240 | Upgrade
|
| Depreciation & Amortization | 382.64 | 491.22 | 533.31 | 417.36 | 245.49 | 140.16 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.32 | Upgrade
|
| Loss (Gain) From Sale of Investments | -273.44 | -66.77 | 40.4 | -105.84 | -125.77 | -31.7 | Upgrade
|
| Stock-Based Compensation | 75.66 | 61.53 | 118.92 | 444.39 | 451.81 | 290.03 | Upgrade
|
| Other Operating Activities | 4,518 | 3,789 | -2,286 | 1,240 | 12,783 | 2,162 | Upgrade
|
| Change in Accounts Receivable | -2.27 | - | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1,543 | -2,232 | -1,951 | -469.56 | 325.6 | -273.85 | Upgrade
|
| Operating Cash Flow | -11,093 | -8,096 | -5,293 | -5,189 | -4,740 | -3,954 | Upgrade
|
| Capital Expenditures | -105.14 | -179.21 | -278.58 | -447.4 | -679.57 | -53.14 | Upgrade
|
| Sale (Purchase) of Intangibles | -93.94 | -55.37 | -12.21 | - | -3.66 | -0.33 | Upgrade
|
| Investment in Securities | 5,680 | 2,648 | 22,221 | 4,184 | -46,780 | -6,752 | Upgrade
|
| Other Investing Activities | -151.8 | -121.79 | - | -0 | - | -66.32 | Upgrade
|
| Investing Cash Flow | 5,329 | 2,291 | 21,930 | 3,736 | -47,463 | -6,872 | Upgrade
|
| Long-Term Debt Issued | - | 10,000 | 10,000 | - | - | 23,000 | Upgrade
|
| Total Debt Issued | - | 10,000 | 10,000 | - | - | 23,000 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -3,000 | Upgrade
|
| Long-Term Debt Repaid | - | -209.64 | -23,671 | -116.29 | -116.29 | -8.7 | Upgrade
|
| Total Debt Repaid | 10.58 | -209.64 | -23,671 | -116.29 | -116.29 | -3,009 | Upgrade
|
| Net Debt Issued (Repaid) | 10.58 | 9,790 | -13,671 | -116.29 | -116.29 | 19,991 | Upgrade
|
| Issuance of Common Stock | 87.38 | 199.9 | 554.71 | - | 44,436 | - | Upgrade
|
| Other Financing Activities | -0 | -0 | -0 | - | - | - | Upgrade
|
| Financing Cash Flow | 97.96 | 9,990 | -13,117 | -116.29 | 44,320 | 19,991 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | 0.17 | 0.04 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | - | - | - | Upgrade
|
| Net Cash Flow | -5,665 | 4,186 | 3,520 | -1,568 | -7,883 | 9,165 | Upgrade
|
| Free Cash Flow | -11,198 | -8,275 | -5,572 | -5,636 | -5,419 | -4,007 | Upgrade
|
| Free Cash Flow Margin | -7059.76% | -2232.46% | -1894.38% | -3140.08% | -1083.83% | -5151.23% | Upgrade
|
| Free Cash Flow Per Share | -417.49 | -308.76 | -210.20 | -213.18 | -232.41 | -223.48 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 99.84 | Upgrade
|
| Cash Income Tax Paid | - | -168.01 | 288.65 | 85.97 | 17.07 | 2.95 | Upgrade
|
| Levered Free Cash Flow | 5,373 | -2,183 | -10,251 | -6,799 | -6,029 | -10,392 | Upgrade
|
| Unlevered Free Cash Flow | 6,688 | -1,378 | -8,607 | -5,195 | -4,703 | -9,869 | Upgrade
|
| Change in Working Capital | -1,545 | -2,232 | -1,951 | -469.56 | 325.6 | -273.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.